A new report commissioned by Bristol Myers Squibb has suggested an approach to the formal horizon scanning that will be introduced under the federal government's new agreement with Medicines Australia.
New report recommends inclusive approach to 'horizon scanning'
May 24, 2022 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
A perspective that rightly belongs in a time capsule from the 1990s
October 23, 2025 - - Latest News -
Global focus intensifies as AusBiotech strengthens trade, partnerships and international engagement
October 23, 2025 - - Australian Biotech -
Queensland resources sector backs prevention-first health push to boost workforce productivity
October 23, 2025 - - Latest News -
Omico appoints Richard Vines as new Chair as it strengthens national precision oncology agenda
October 23, 2025 - - Latest News -
New Zealand identified as a ‘major outlier’ in OECD medicines investment
October 23, 2025 - - BioPharma -
Island Pharmaceuticals secures FDA response date for Galidesivir approval pathway
October 23, 2025 - - Australian Biotech -
Noxopharm granted first US patent for Sofra immune-modulation platform
October 23, 2025 - - Australian Biotech